The antiischemic effects of tedisamil were investigated in chronically instrumented conscious dogs. Heart rate, arterial blood pressure, left ventricular dP/dtma x, left ventricular end-diastolic pressure, and regional myocardial shortening in the ischemic and normal myocardium, assessed by sonomicrometry, were measured. Reversible regional myocardial dysfunction was achieved by graded treadmill exercise in the presence of a critical coronary stenosis, which was produced by partial inflation of a hydraulic occluder. Regional myocardial dysfunction, which was observed before the intravenous drug administration, was almost completely abolished by tedisamil (180 p.g/kg/5min). The antiischemic effect of tedisamil is due to a reduction in heart rate, which leads to a decrease in left ventricular dP/dtm~_, and myocardial oxygen demand in the presence of a prolongation of diastole and thus coronary perfusion time. Clinical evaluation will test the value of this drug for the treatment of stressinduced symptomatic and asymptomatic angina pectoris in humans.Tedisamil is a sinus-node inhibitor with K+-channel blocking activity. Other bradycardic drugs that belong to this group are the specific bradycardic agents alinidine and zatebradine (ULFS 49). In contrast to beta-adrenoceptor antagonists, specific bradycardic agents lead to a reduction in heart rate but do not reduce myocardial contractility. Tedisamil was shown to have no or only a negligible negative inotropic effect [1,2].Heart rate is a major determinant of myocardial oxygen needs [3]. Thus decreases in heart rate lead, on the one hand, to a decrease in myocardial oxygen consumption and, on the other hand, to a marked prolongation of diastolic time. Since coronary blood flow occurs mainly during diastole, a decrease in heart rate, and thus an increase in diastolic time, allows a better blood supply and hence oxygen availability, especially in the subendocardial myocardium.Alinidine and zatebradine, both specific bradycardic agents, were shown to abolish regional myocardial dysfunction in a model of exercise-induced regional myocardial underperfusion [4,5]. We therefore investigated the effects of tedisamil in this model [6], which mimicks the hemodynamic features of exerciseinduced myocardial dysfunction in humans.
Materials and Methods Chronic instrumentationThe animals used in this study were handled in accordance with the animal welfare regulations of the University of Vienna. The experimental protocol was approved by the Animal Subjects Committee of this institution and the Ministry of Science.The study was carried out in six mongrel dogs weighing between 25 and 32 kg. The animals were vaccinated with Candivac SHLT (distemper, hepatitis, leptospirosis, rabies) and Candur P (parvovirosis), and were free of parasites. They received Loyal dry food (Tagger & Co., Graz) as standard diet and had free access to water. Prior to instrumentation the dogs were trained to stand quietly and to run on a treadmill (Quinton model 1854). In order to keep the animals accustomed ...